Clovis Oncology, Inc. — Form D
Clovis Oncology, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-27. $192.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-11-27
- Form: D
- Accession: 0001466301-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $192.0M
- Investors: 9
- Date of first sale: 2013-11-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-207178
Issuer
- Name: Clovis Oncology, Inc.
- CIK: 0001466301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1871 FOLSOM STREET, BOULDER, CO, 80302
- Phone: (720) 220-9122
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Brian G Atwood | Director | Gaithersburg, MD |
| M. James Barret | Director | Boulder, CO |
| JAMES C BLAIR | Director | WOBURN, MA |
| Keith L Flaherty | Director | Boulder, CO |
| Ginger L Graham | Director | Westminster, CO |
| Paul C Klingenstein | Director | Boulder, CO |
| Patrick J Mahaffy | Director | La Jolla, CA |
| Edward J McKinley | Director | Boulder, CO |
| Thorlef J Spickschen | Director | Boulder, CO |
| Andrew R Allen | Executive Officer | Boulder, CO |
| Steven L Hoerter | Executive Officer | Boulder, CO |
| Gillian C Ivers-Read | Executive Officer | Boulder, CO |
| Patrick J Mahaffy | Executive Officer | La Jolla, CA |
| Erle T Mast | Executive Officer | Boulder, CO |
Other filings by this issuer (4)
More